State laws setting the scope and limits of emergency authority are crucial to an effective public health response. This suite of legal data captures details of legislation that addresses emergency health authority introduced between January 1, 2021, and May 20, 2022, in all 50 US states and the District of Columbia.
This dataset presents state-level statutes and regulations on prescription drug monitoring program (PDMP) laws covering reporting requirements, mandates requiring providers to check PDMP databases before prescribing controlled substances, and provisions regulating access.
On June 24, 2022, the US Supreme Court’s decision in Dobbs v. Jackson Women’s Health Organization overturned nearly 50 years of precedent protecting the right to an abortion prior to viability. Under Roe v. Wade, the legal landscape of abortion was a complex patchwork of state laws and court decisions regulating access to the procedure. The Dobbs decision further compromised abortion access by allowing states to ban all or most abortions.
To mitigate morbidity and mortality associated with prescription opioids, most states have implemented limits on opioid analgesic prescribing. Approaches vary, but these laws generally restrict the duration of an opioid prescriptions by the number of days supplied. Some states additionally limit the daily dosage or total dosage allowed in opioid prescriptions.
This dataset presents state-level statutes and regulations across all 50 states and the District of Columbia in effect between January 1, 2014 and December 31, 2019.
This research collected Financial Assistance Policies and related debt collection policies from a representative sample of 75 340B hospitals to better understand financial support for pharmaceuticals for low-income populations.
This dataset on LawAtlas.org explores statutes and regulations addressing school lunch policies in all 50 U.S. states and the District of Columbia. This dataset is valid through April 1, 2021.
This dataset is cross-sectional and displays key features of state Medicaid Waivers addressing COVID-19 across all 50 states and the District of Columbia approved as of July 1, 2021.
This dataset, published on PDAPS.org, is cross-sectional and displays key features of state laws increasing access to buprenorphine and methadone during COVID-19 across all 50 states and the District of Columbia approved as of June 1, 2021.
